Severe Autoimmune Diseases View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2020-07-01

AUTHORS

Melanie Henes , Michael von Wolff , Joerg Henes

ABSTRACT

This section deals with ovarian protection in non-malignant, rheumatic or other autoimmune diseases. Since these diseases are disproportionately common in young women, knowledge of the negative effects of immunosuppressive agents on the ovarian reserve, as well as the possibilities and limitations of ovarian protective measures, even in this particular patient population, is essential. According to current data, we should offer patients at increased risk of POI treatment with GnRH analogues when using cyclophosphamide. In addition, the use of ovarian cryopreservation (short time frame, sufficiently high ovarian reserve) should be generously considered. Ovarian stimulation therapy is only advisable in rare cases, as many patients are at risk of exacerbation of the underlying disease. More... »

PAGES

123-131

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15

DOI

http://dx.doi.org/10.1007/978-3-030-47568-0_15

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1128882857


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, Tuebingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411544.1", 
          "name": [
            "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Henes", 
        "givenName": "Melanie", 
        "id": "sg:person.01156232223.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156232223.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.411656.1", 
          "name": [
            "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Wolff", 
        "givenName": "Michael", 
        "id": "sg:person.0610777233.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610777233.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital Tuebingen, Tuebingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411544.1", 
          "name": [
            "Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital Tuebingen, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Henes", 
        "givenName": "Joerg", 
        "id": "sg:person.010365700347.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010365700347.66"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2020-07-01", 
    "datePublishedReg": "2020-07-01", 
    "description": "This section deals with ovarian protection in non-malignant, rheumatic or other autoimmune diseases. Since these diseases are disproportionately common in young women, knowledge of the negative effects of immunosuppressive agents on the ovarian reserve, as well as the possibilities and limitations of ovarian protective measures, even in this particular patient population, is essential. According to current data, we should offer patients at increased risk of POI treatment with GnRH analogues when using cyclophosphamide. In addition, the use of ovarian cryopreservation (short time frame, sufficiently high ovarian reserve) should be generously considered. Ovarian stimulation therapy is only advisable in rare cases, as many patients are at risk of exacerbation of the underlying disease.", 
    "editor": [
      {
        "familyName": "von Wolff", 
        "givenName": "Michael", 
        "type": "Person"
      }, 
      {
        "familyName": "Nawroth", 
        "givenName": "Frank", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-030-47568-0_15", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-030-47567-3", 
        "978-3-030-47568-0"
      ], 
      "name": "Fertility Preservation in Oncological and Non-Oncological Diseases", 
      "type": "Book"
    }, 
    "keywords": [
      "autoimmune diseases", 
      "ovarian stimulation therapy", 
      "risk of exacerbations", 
      "severe autoimmune disease", 
      "particular patient population", 
      "POI treatment", 
      "ovarian protection", 
      "ovarian reserve", 
      "underlying disease", 
      "immunosuppressive agents", 
      "ovarian cryopreservation", 
      "GnRH analogues", 
      "patient population", 
      "stimulation therapy", 
      "rare case", 
      "young women", 
      "disease", 
      "patients", 
      "current data", 
      "risk", 
      "protective measures", 
      "cyclophosphamide", 
      "exacerbation", 
      "therapy", 
      "women", 
      "treatment", 
      "population", 
      "agents", 
      "cryopreservation", 
      "negative effects", 
      "cases", 
      "measures", 
      "effect", 
      "protection", 
      "use", 
      "analogues", 
      "data", 
      "addition", 
      "knowledge", 
      "reserves", 
      "sections", 
      "limitations", 
      "possibility"
    ], 
    "name": "Severe Autoimmune Diseases", 
    "pagination": "123-131", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1128882857"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-030-47568-0_15"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-030-47568-0_15", 
      "https://app.dimensions.ai/details/publication/pub.1128882857"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-10-01T06:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/chapter/chapter_226.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-030-47568-0_15"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15'


 

This table displays all metadata directly associated to this object as RDF triples.

126 TRIPLES      22 PREDICATES      67 URIs      60 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-030-47568-0_15 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author N5def8d09dd9647e6858f2c6d92678d36
4 schema:datePublished 2020-07-01
5 schema:datePublishedReg 2020-07-01
6 schema:description This section deals with ovarian protection in non-malignant, rheumatic or other autoimmune diseases. Since these diseases are disproportionately common in young women, knowledge of the negative effects of immunosuppressive agents on the ovarian reserve, as well as the possibilities and limitations of ovarian protective measures, even in this particular patient population, is essential. According to current data, we should offer patients at increased risk of POI treatment with GnRH analogues when using cyclophosphamide. In addition, the use of ovarian cryopreservation (short time frame, sufficiently high ovarian reserve) should be generously considered. Ovarian stimulation therapy is only advisable in rare cases, as many patients are at risk of exacerbation of the underlying disease.
7 schema:editor N4d9bffa5903743289a35d8481855a8b9
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N369f4a88ae114d409715bdc5d5c8e4ba
11 schema:keywords GnRH analogues
12 POI treatment
13 addition
14 agents
15 analogues
16 autoimmune diseases
17 cases
18 cryopreservation
19 current data
20 cyclophosphamide
21 data
22 disease
23 effect
24 exacerbation
25 immunosuppressive agents
26 knowledge
27 limitations
28 measures
29 negative effects
30 ovarian cryopreservation
31 ovarian protection
32 ovarian reserve
33 ovarian stimulation therapy
34 particular patient population
35 patient population
36 patients
37 population
38 possibility
39 protection
40 protective measures
41 rare case
42 reserves
43 risk
44 risk of exacerbations
45 sections
46 severe autoimmune disease
47 stimulation therapy
48 therapy
49 treatment
50 underlying disease
51 use
52 women
53 young women
54 schema:name Severe Autoimmune Diseases
55 schema:pagination 123-131
56 schema:productId N9005a98a1ae4432bbe45ce8e036c44a0
57 Naa6a0e6a58ab443d9238eed2f54dcf78
58 schema:publisher N94e13ede0f4d4fffba8901c62e49582f
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128882857
60 https://doi.org/10.1007/978-3-030-47568-0_15
61 schema:sdDatePublished 2022-10-01T06:54
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N56aee461734648b0b12a038ce0df54d6
64 schema:url https://doi.org/10.1007/978-3-030-47568-0_15
65 sgo:license sg:explorer/license/
66 sgo:sdDataset chapters
67 rdf:type schema:Chapter
68 N369f4a88ae114d409715bdc5d5c8e4ba schema:isbn 978-3-030-47567-3
69 978-3-030-47568-0
70 schema:name Fertility Preservation in Oncological and Non-Oncological Diseases
71 rdf:type schema:Book
72 N3aed22aaf9f34ac7bec45c88ae97da04 schema:familyName Nawroth
73 schema:givenName Frank
74 rdf:type schema:Person
75 N4d9bffa5903743289a35d8481855a8b9 rdf:first N6555b0c1a719495a8c2eb5360a24492a
76 rdf:rest N5c9f8802a69e4840931923f7d008efa9
77 N56aee461734648b0b12a038ce0df54d6 schema:name Springer Nature - SN SciGraph project
78 rdf:type schema:Organization
79 N5c9f8802a69e4840931923f7d008efa9 rdf:first N3aed22aaf9f34ac7bec45c88ae97da04
80 rdf:rest rdf:nil
81 N5def8d09dd9647e6858f2c6d92678d36 rdf:first sg:person.01156232223.05
82 rdf:rest N821519ce3b5f4f2097ff12d695bc9618
83 N6555b0c1a719495a8c2eb5360a24492a schema:familyName von Wolff
84 schema:givenName Michael
85 rdf:type schema:Person
86 N69ed70853a31453683edca70e0e067cc rdf:first sg:person.010365700347.66
87 rdf:rest rdf:nil
88 N821519ce3b5f4f2097ff12d695bc9618 rdf:first sg:person.0610777233.66
89 rdf:rest N69ed70853a31453683edca70e0e067cc
90 N9005a98a1ae4432bbe45ce8e036c44a0 schema:name doi
91 schema:value 10.1007/978-3-030-47568-0_15
92 rdf:type schema:PropertyValue
93 N94e13ede0f4d4fffba8901c62e49582f schema:name Springer Nature
94 rdf:type schema:Organisation
95 Naa6a0e6a58ab443d9238eed2f54dcf78 schema:name dimensions_id
96 schema:value pub.1128882857
97 rdf:type schema:PropertyValue
98 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
99 schema:name Medical and Health Sciences
100 rdf:type schema:DefinedTerm
101 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
102 schema:name Immunology
103 rdf:type schema:DefinedTerm
104 sg:person.010365700347.66 schema:affiliation grid-institutes:grid.411544.1
105 schema:familyName Henes
106 schema:givenName Joerg
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010365700347.66
108 rdf:type schema:Person
109 sg:person.01156232223.05 schema:affiliation grid-institutes:grid.411544.1
110 schema:familyName Henes
111 schema:givenName Melanie
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156232223.05
113 rdf:type schema:Person
114 sg:person.0610777233.66 schema:affiliation grid-institutes:grid.411656.1
115 schema:familyName von Wolff
116 schema:givenName Michael
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610777233.66
118 rdf:type schema:Person
119 grid-institutes:grid.411544.1 schema:alternateName Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital Tuebingen, Tuebingen, Germany
120 Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, Tuebingen, Germany
121 schema:name Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital Tuebingen, Tuebingen, Germany
122 Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, Tuebingen, Germany
123 rdf:type schema:Organization
124 grid-institutes:grid.411656.1 schema:alternateName Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, University of Bern, Bern, Switzerland
125 schema:name Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, University of Bern, Bern, Switzerland
126 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...